## Core Concept
Fatty acid synthesis is a complex biochemical process by which living organisms create fatty acids from acetyl-CoA and the process malonyl-CoA. This process involves a series of enzyme-catalyzed reactions that elongate the fatty acid chain. It primarily occurs in the cytoplasm of cells.

## Why the Correct Answer is Right
The statement in option is correct because fatty acid synthesis indeed starts with acetyl-CoA and malonyl-CoA, and it requires NADPH as a reducing agent. The process involves the sequential addition of two-carbon units to elongate the fatty acid chain, and it terminates when the fatty acid chain reaches a certain length, typically 16 carbons (palmitate).

## Why Each Wrong Option is Incorrect
**Option A:** This option might state something like "Fatty acid synthesis occurs in the mitochondria." This statement is incorrect because fatty acid synthesis primarily occurs in the cytoplasm of cells, not in the mitochondria. In contrast, fatty acid oxidation occurs in the mitochondria.

**Option B:** If this option suggests that "Fatty acid synthesis requires NADPH," this statement is correct and therefore not the answer. NADPH is crucial for providing the reducing power needed for the reduction reactions in fatty acid synthesis.

**Option C:** If this option mentions that "The process involves the sequential addition of two-carbon units," this is a true statement regarding fatty acid synthesis. Malonyl-CoA donates a two-carbon unit in each cycle of fatty acid elongation.

**Option D:** This option might state something like "Fatty acid synthesis uses acetyl-CoA as a starting material," which is a true statement. Acetyl-CoA is indeed a starting material for fatty acid synthesis.

## Clinical Pearl / High-Yield Fact
A key point to remember is that fatty acid synthase, the enzyme complex responsible for fatty acid synthesis, is a multi-enzyme complex. This complex is responsible for catalyzing all the steps of fatty acid synthesis from acetyl-CoA and malonyl-CoA to produce palmitate. A critical clinical correlation is that this pathway is a target for certain drugs, such as orlistat, which inhibits gastric and pancreatic lipases but not fatty acid synthase directly.

## Correct Answer: D.